Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11780875 Neuroactive steroids, compositions, and uses thereof

Patent 11780875 was granted and assigned to SAGE Therapeutics on October, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

SAGE Therapeutics

Current Assignee

SAGE Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Boyd L. Harrison

Albert Jean Robichaud

Francesco G. Salituro

Gabriel Martinez Botella

Date of Patent

October 10, 2023

Patent Application Number

17472744

Date Filed

September 13, 2021

Patent Citations

US Patent 9512165 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

US Patent 9630986 Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same

US Patent 9725481 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

US Patent 10246482 Neuroactive steroids, compositions, and uses thereof

US Patent 9765110 Neuroactive 19-alkoxy-17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same

US Patent 7781421 Neuroactive 13, 24-cyclo-18, 21-dinorcholanes and structurally related pentacyclic steriods

US Patent 8759330 Neuroactive 13,24-cyclo-18,21-dinorcholanes and structurally related pentacylic steroids

US Patent 8939545 Inkjet printing with managed airflow for condensation control

...

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11780875 Neuroactive steroids, compositions, and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool